Phio Pharmaceuticals Corp.
SEC 4 · Filed
0001683168-26-008786Accepted
Applies to the EDGAR acceptance time.
Other time zone
Insider transactionsEvent date Nov 13, 2026
- Security
- Common Stock, $.0001 par value
- Shares
-
3,000
- Price per share
-
0.83
Reported 0.8334
Structured facts
{
"code": "P",
"date": "2026-11-13",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Includes shares of common stock underlying unvested restricted stock units."
},
"owners": [
{
"cik": "0001641063",
"name": "Deming David H",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "61800",
"price": "0.8334",
"row": 2,
"rule_10b5_1": "0",
"security": "Common Stock, $.0001 par value",
"shares": "3000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}Insider transactionsEvent date Nov 12, 2026
- Security
- Common Stock, $.0001 par value
- Shares
-
9,000
- Price per share
-
0.81
Reported 0.8136
Structured facts
{
"code": "P",
"date": "2026-11-12",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "Includes shares of common stock underlying unvested restricted stock units."
},
"owners": [
{
"cik": "0001641063",
"name": "Deming David H",
"roles": [
"director"
],
"title": null
}
],
"ownership": "D",
"post_shares": "58800",
"price": "0.8136",
"row": 1,
"rule_10b5_1": "0",
"security": "Common Stock, $.0001 par value",
"shares": "9000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}